Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
出版年份 2016 全文链接
标题
Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin
作者
关键词
TRAIL, Kv10.1, Apoptosis, Chemotherapy resistance, Cancer therapy
出版物
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
Volume 45, Issue 7, Pages 709-719
出版商
Springer Nature
发表日期
2016-06-27
DOI
10.1007/s00249-016-1149-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Periodic expression of Kv10.1 driven by pRb/E2F1 contributes to G2/M progression of cancer and non-transformed cells
- (2016) Diana Urrego et al. CELL CYCLE
- Kv10.1 K+ channel: from physiology to cancer
- (2016) Halima Ouadid-Ahidouch et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Analysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival
- (2015) Ramón Martínez et al. BMC CANCER
- Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
- (2015) Silvia von Karstedt et al. CANCER CELL
- Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
- (2015) María de Guadalupe Chávez-López et al. TUMOR BIOLOGY
- Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study
- (2015) Chan Yoon Cheah et al. Lancet Haematology
- Prediction of Cancer Drug Resistance and Implications for Personalized Medicine
- (2015) Manfred Volm et al. Frontiers in Oncology
- An overview of doxorubicin formulations in cancer therapy
- (2015) Sangeeta Rivankar Journal of Cancer Research and Therapeutics
- C-FLIP(L) contributes to TRAIL resistance in HER2-positive breast cancer
- (2014) Fenglin Zang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors
- (2014) Janice García-Quiroz et al. BMC CANCER
- Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
- (2014) Feifei Xu et al. Cancer Cell International
- The Molecular Mechanisms of TRAIL Resistance in Cancer Cells: Help in Designing New Drugs
- (2014) Feng Wang et al. CURRENT PHARMACEUTICAL DESIGN
- Density-dependent lineage instability of MDA-MB-435 breast cancer cells
- (2013) ANDREAS G. NERLICH et al. Oncology Letters
- Ether à go-go 1 Silencing in Combination with TRAIL Overexpression Has Synergistic Antitumor Effects on Osteosarcoma
- (2012) Jin Wu et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Targeting Tumour-Initiating Cells with TRAIL Based Combination Therapy Ensures Complete and Lasting Eradication of Multiple Myeloma Tumours In Vivo
- (2012) Srdjan Vitovski et al. PLoS One
- ERK1/2 Signaling Plays an Important Role in Topoisomerase II Poison-Induced G2/M Checkpoint Activation
- (2012) Ryan H. Kolb et al. PLoS One
- Eag1 Channels as Potential Cancer Biomarkers
- (2012) Jesús Adrián Rodríguez-Rasgado et al. SENSORS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Tumor cell-selective apoptosis induction through targeting of KV10.1 via bifunctional TRAIL antibody
- (2011) Franziska Hartung et al. Molecular Cancer
- A Novel DNA Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells
- (2010) Ning Wu et al. BIOCHEMISTRY
- TRAIL and Doxorubicin Combination Induces Proapoptotic and Antiangiogenic Effects in Soft Tissue Sarcoma In vivo
- (2010) S. Wang et al. CLINICAL CANCER RESEARCH
- Ion channels and the hallmarks of cancer
- (2010) Natalia Prevarskaya et al. TRENDS IN MOLECULAR MEDICINE
- MDA-MB-435 cells are from melanoma, not from breast cancer
- (2008) Marc Lacroix CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway
- (2008) S Shamimi-Noori et al. CANCER GENE THERAPY
- Metastasis Suppressor Function of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-R in Mice: Implications for TRAIL-Based Therapy in Humans?
- (2008) A. Grosse-Wilde et al. CANCER RESEARCH
- TRAIL receptor signalling and modulation: Are we on the right TRAIL?
- (2008) Devalingam Mahalingam et al. CANCER TREATMENT REVIEWS
- Roscovitine sensitizes breast cancer cells to TRAIL-induced apoptosis through a pleiotropic mechanism
- (2008) Gustavo Ortiz-Ferrón et al. CELL RESEARCH
- Eag1 Expression Interferes with Hypoxia Homeostasis and Induces Angiogenesis in Tumors
- (2008) Bryan R. Downie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started